DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BMS-823778
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
BMS-823778
×
Maximum Phase:
2
First Approval:
None
UNII:
8JYO8VTR11
Molecule Type:
Small molecule
Molecular Formula:
C18H19Cl2N3O
Molecular Weight:
364.28
AlogP:
3.69
PSA:
50.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SAR425899
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor agonist
SAR425899
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLORBENAZINE F 18
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLORBENAZINE F 18
×
Maximum Phase:
2
First Approval:
None
UNII:
KM31LBX59H
Molecule Type:
Small molecule
Molecular Formula:
C21H32FNO3
Molecular Weight:
364.49
AlogP:
3.76
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ELIPRODIL
2
Small molecule
Investigational
Unknown
Unknown
Movement Disorders; Parkinson Disease
Unknown
ELIPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
YW62A6TW29
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClFNO
Molecular Weight:
347.86
AlogP:
4.47
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DIAZEPINOMICIN
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
DIAZEPINOMICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
YPH994Y0RF
Molecule Type:
Small molecule
Molecular Formula:
C28H34N2O4
Molecular Weight:
462.59
AlogP:
6.93
PSA:
93.03
HBD:
4.0
HBA:
#RotB:
8.0
Source:
GSK-1070806
2
Antibody
Investigational
Unknown
Unknown
Crohn Disease; Dermatitis, Atopic; Inflammatory Bowel Diseases; Behcet Syndrome; Diabetes Mellitus
Interleukin-18 inhibitor
GSK-1070806
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRANILAST
2
Small molecule
Investigational
Unknown
Unknown
Sarcoidosis; Scleredema Adultorum; Arthritis, Rheumatoid; Pterygium
Unknown
TRANILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
HVF50SMY6E
Molecule Type:
Small molecule
Molecular Formula:
C18H17NO5
Molecular Weight:
327.34
AlogP:
3.05
PSA:
84.86
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NOV-002
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NOV-002
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADOMEGLIVANT
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Glucagon receptor antagonist
ADOMEGLIVANT
×
Maximum Phase:
2
First Approval:
None
UNII:
74Z5ZL2KVG
Molecule Type:
Small molecule
Molecular Formula:
C32H36F3NO4
Molecular Weight:
555.64
AlogP:
7.94
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
10.0
Source:
DONU
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DONU
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAMILUMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis; Spondylitis, Ankylosing
Granulocyte-macrophage colony-stimulating factor inhibitor
NAMILUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
MED485W763
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSLINANIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Neoplasms; Carcinoma, Hepatocellular
Unknown
FOSLINANIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2X2DNM7NGX
Molecule Type:
Small molecule
Molecular Formula:
C16H13FNO6P
Molecular Weight:
365.25
AlogP:
2.81
PSA:
108.85
HBD:
3.0
HBA:
#RotB:
4.0
Source:
LUSVERTIKIMAB
2
Antibody
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
LUSVERTIKIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRYOSTATIN 1
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BRYOSTATIN 1
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TZP-102
2
Protein
Investigational
Unknown
Unknown
Gastroparesis
Ghrelin receptor agonist
TZP-102
×
Maximum Phase:
2
First Approval:
None
UNII:
9NFY3MS3SL
Molecule Type:
Protein
Molecular Formula:
C28H44N4O4
Molecular Weight:
500.68
AlogP:
2.65
PSA:
99.77
HBD:
3.0
HBA:
#RotB:
3.0
Source:
EMIBETUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Stomach Neoplasms
Hepatocyte growth factor receptor inhibitor
EMIBETUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
MO4K3GDN1I
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TONAPOFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Heart Failure; Renal Insufficiency
Adenosine A1 receptor antagonist
TONAPOFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
83VNU4U44T
Molecule Type:
Small molecule
Molecular Formula:
C22H32N4O4
Molecular Weight:
416.52
AlogP:
3.16
PSA:
109.98
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IDOXIFENE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor modulator
IDOXIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
456UXE9867
Molecule Type:
Small molecule
Molecular Formula:
C28H30INO
Molecular Weight:
523.46
AlogP:
7.13
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
LY2196044
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY2196044
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALUGRASTIM
2
Protein
Investigational
Unknown
Unknown
Neoplasms
Granulocyte colony stimulating factor receptor agonist
BALUGRASTIM
×
Maximum Phase:
2
First Approval:
None
UNII:
T6K4P3HIU8
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CINNAMON
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Obesity; Dental Caries; Diabetes Mellitus; Polycystic Ovary Syndrome
Unknown
CINNAMON
×
Maximum Phase:
2
First Approval:
None
UNII:
5S29HWU6QB
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EZALADCIGENE RESOPARVOVEC
2
Gene
Investigational
Unknown
Unknown
Parkinson Disease
Unknown
EZALADCIGENE RESOPARVOVEC
×
Maximum Phase:
2
First Approval:
None
UNII:
2WRS0PE04O
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLESTRA
2
Unknown
Investigational
Unknown
Unknown
Obesity
Unknown
OLESTRA
×
Maximum Phase:
2
First Approval:
None
UNII:
6742Y30KGK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MS1819-SD
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MS1819-SD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
81C6 131I
2
Antibody
Investigational
Unknown
Unknown
Unknown
Tenascin binding agent
81C6 131I
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DWP05195
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic
Vanilloid receptor antagonist
DWP05195
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELTA 8-TETRAHYDROCANNOBINOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
DELTA 8-TETRAHYDROCANNOBINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
B49D0HH807
Molecule Type:
Small molecule
Molecular Formula:
C21H30O2
Molecular Weight:
314.47
AlogP:
5.74
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
KANGLAITE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
KANGLAITE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(-)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary; Muscular Dystrophy, Duchenne
Unknown
(-)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
34PHS7TU43
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
SAR-279356
2
Antibody
Investigational
Unknown
Unknown
Infections
Poly-N-acetylglucosamine binding agent
SAR-279356
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGAMOTECAN
2
Small molecule
Investigational
Unknown
Unknown
Sarcoma
Unknown
PEGAMOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ZY7ZTE7LFH
Molecule Type:
Small molecule
Molecular Formula:
C52H48N6O14
Molecular Weight:
980.98
AlogP:
3.32
PSA:
251.64
HBD:
2.0
HBA:
#RotB:
15.0
Source:
TRANSCON CNP
2
Unknown
Investigational
Unknown
Unknown
Achondroplasia
Unknown
TRANSCON CNP
×
Maximum Phase:
2
First Approval:
None
UNII:
Y3BH8M899D
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAXIFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
NAXIFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
B3G45WC37L
Molecule Type:
Small molecule
Molecular Formula:
C18H24N4O3
Molecular Weight:
344.42
AlogP:
1.6
PSA:
85.21
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PD-L1
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PD-L1
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMOLADAGENE AUTOTEMCEL
2
Gene
Investigational
Unknown
Unknown
Severe Combined Immunodeficiency
Unknown
SIMOLADAGENE AUTOTEMCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
MOD3RG31RS
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
159
160
161
162
163
164
165
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA